سعر فينوريلبين ايبوي Vinorelbin-ebewe‏ 10مجم فيال 2026

• Most common (>=20%): leukopenia, neutropenia, anemia, increased AST, nausea, vomiting, constipation, asthenia, injection site reaction, peripheral neuropathy.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• The US label lists no contraindications.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: severe myelosuppression resulting in serious infection, septic shock and death can occur; decrease the dose or withhold according to neutrophil counts.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Hepatic toxicity, severe constipation/bowel obstruction, extravasation tissue injury, severe sensory and motor neuropathy, pulmonary toxicity and embryo-fetal toxicity are reported; monitor and manage as per label.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• CYP3A inhibitorsConcurrent CYP3A inhibitors may cause earlier onset and/or increased severity of adverse reactions.DailyMed (U.S. National Library of Medicine)

English text not available for this section.